[HTML][HTML] Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone in patients with transplant-ineligible newly …
Introduction: Daratumumab (DARA) is a human IgGκ monoclonal antibody targeting CD38
with a direct on-tumor and immunomodulatory mechanism of action. The addition of DARA …
with a direct on-tumor and immunomodulatory mechanism of action. The addition of DARA …
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed …
MV Mateos, M Cavo, J Bladé, MA Dimopoulos… - 2019 - ashpublications.org
Introduction: Daratumumab (DARA) is a human IgGκ monoclonal antibody targeting CD38
with a direct on-tumor and immunomodulatory mechanism of action. The addition of DARA …
with a direct on-tumor and immunomodulatory mechanism of action. The addition of DARA …